All Companies
Ticker TVTX
Foundation Sweep — share basis uncertain
You reached the page — here's exactly what TVTX is, and why it's out of scope for now.
What this ticker is
TVTX
Travere Therapeutics Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $6.1B
Travere Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for people living with rare kidney, liver, and metabolic diseases. Its current commercial portfolio includes FILSPARI, a treatment for certain kidney disorders, along with legacy rare-disease products such as Thiola, Thiola EC, Cholbam, and Chenodal.…
Why we can't analyze it yet
F5 · Thin bench — a small/young filer with no cover-page count; nothing contradicts the divisor · HELD — integrity: 1 known-bad value(s) at severity ≥ 90
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
share_basis_unverified